Cargando…
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
Autores principales: | Mailhot Vega, Raymond B., Castellino, Sharon M., Pei, Qinglin, Parsons, Susan, Roberts, Kenneth B., Hodgson, David, Charpentier, Anne-Marie, Fitzgerald, Thomas J., Kessel, Sandy K., Keller, Frank G., Kelly, Kara, Hoppe, Bradford S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Particle Therapy Co-operative Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768892/ https://www.ncbi.nlm.nih.gov/pubmed/35127976 http://dx.doi.org/10.14338/IJPT-21-00012.1 |
Ejemplares similares
-
Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study
por: Parsons, Susan K., et al.
Publicado: (2023) -
Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children’s Oncology Group protocol AHOD0031
por: McCarten, Kathleen M., et al.
Publicado: (2018) -
T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma
por: Castellino, Sharon M., et al.
Publicado: (2022) -
P086: Advancing Pediatric Hodgkin Lymphoma Research Through NODAL
por: Flerlage, Jamie E., et al.
Publicado: (2022) -
Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
por: Hoppe, Bradford S., et al.
Publicado: (2020)